- Home
- GMED vs ELAN Comparison
GMED vs ELAN Comparison
Compare GMED & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- ELAN
- Stock Information
- Founded
- GMED 2003
- ELAN 1954
- Country
- GMED United States
- ELAN United States
- Employees
- GMED N/A
- ELAN N/A
- Industry
- GMED Medical/Dental Instruments
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- GMED Health Care
- ELAN Health Care
- Exchange
- GMED Nasdaq
- ELAN Nasdaq
- Market Cap
- GMED 8.1B
- ELAN 6.6B
- IPO Year
- GMED 2012
- ELAN 2018
- Fundamental
- Price
- GMED $59.51
- ELAN $14.77
- Analyst Decision
- GMED Buy
- ELAN Buy
- Analyst Count
- GMED 13
- ELAN 7
- Target Price
- GMED $94.30
- ELAN $15.33
- AVG Volume (30 Days)
- GMED 1.1M
- ELAN 5.3M
- Earning Date
- GMED 08-05-2025
- ELAN 08-07-2025
- Dividend Yield
- GMED N/A
- ELAN N/A
- EPS Growth
- GMED 145.70
- ELAN N/A
- EPS
- GMED 1.34
- ELAN 0.75
- Revenue
- GMED $2,510,810,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- GMED $15.47
- ELAN $4.28
- Revenue Next Year
- GMED $8.97
- ELAN $4.67
- P/E Ratio
- GMED $45.45
- ELAN $19.61
- Revenue Growth
- GMED 32.26
- ELAN 1.42
- 52 Week Low
- GMED $54.48
- ELAN $8.02
- 52 Week High
- GMED $94.93
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- GMED 47.52
- ELAN 71.60
- Support Level
- GMED $57.79
- ELAN $14.01
- Resistance Level
- GMED $61.29
- ELAN $14.15
- Average True Range (ATR)
- GMED 1.28
- ELAN 0.39
- MACD
- GMED 0.43
- ELAN 0.02
- Stochastic Oscillator
- GMED 60.51
- ELAN 97.27
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.